Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.150
+0.020 (0.94%)
At close: May 1, 2026, 4:00 PM EDT
2.148
-0.002 (-0.11%)
After-hours: May 1, 2026, 7:59 PM EDT
Allogene Therapeutics Analyst Ratings
Total Analysts
15
Consensus Rating
Strong Buy
Price Target
$8.35
Upside
+288.37%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Apr 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +411.63% | Apr 16, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $6 → $10 | Strong Buy | Maintains | $6 → $10 | +365.12% | Apr 15, 2026 |
| Bernstein | Bernstein | Hold Maintains $1.6 → $3.85 | Hold | Maintains | $1.6 → $3.85 | +79.07% | Apr 14, 2026 |
| Argus Research | Argus Research | Hold Maintains $1.6 → $3.85 | Hold | Maintains | $1.6 → $3.85 | +79.07% | Apr 14, 2026 |
| Citizens | Citizens | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +272.09% | Apr 14, 2026 |
| Baird | Baird | Buy Maintains $7 → $9 | Buy | Maintains | $7 → $9 | +318.60% | Apr 14, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +458.14% | Apr 14, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +551.16% | Mar 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +272.09% | Mar 13, 2026 |
| Citizens | Citizens | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +132.56% | Jan 9, 2026 |
| UBS | UBS | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +272.09% | Jan 7, 2026 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Oct 10, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 4, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 4, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +225.58% | Aug 1, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.